Cite
HARVARD Citation
Rosen, N. et al. (2019). Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine. Headache. 59 (4), pp. 627-628. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rosen, N. et al. (2019). Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine. Headache. 59 (4), pp. 627-628. [Online].